EHCEncompass Health Corporation
Is it safe?
Nothing alarming, nothing pristine: insiders quiet, comfortable debt (A), and typical volatility.
Insiders were net sellers (-$26.4M, 90 days to Oct 8, 2026), selling is often routine.
Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.
Moderate price swings, typical volatility. Worst drawdown -40% · now 3% below its 52-week high.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can EHC take a bad year?
Encompass Health Corporation carries $2.53B of net debt at 1.73× EBITDA: a load its earnings can carry.
Net debt · as at Q2 2026 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 1.73×
Net debt / EBITDA · 1.84× a year ago · the load is coming down
- Interest cover
- 8.89×
Interest cover · operating profit covers the interest bill several times over
- Annualised volatility
- 28%
Annualised volatility · about as steady as the market itself
Details›
- Total debtQ2 2026
- $2.63B
- Cash and short-term investments
- $108M
- Net debt
- $2.53B
- EBITDA, trailing twelve months
- $1.46B
- Operating profit, trailing twelve months
- $1.12B
- Debt / equity
- 1.01×
- Total debt / EBITDA
- 1.80×
- Annualised volatilitytwo years of daily moves
- 28%
- Worst drawdown on file
- −40%
- Below its 52-week high
- 2.8%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.